0001437749-18-011838.txt : 20180614
0001437749-18-011838.hdr.sgml : 20180614
20180614163451
ACCESSION NUMBER: 0001437749-18-011838
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180613
FILED AS OF DATE: 20180614
DATE AS OF CHANGE: 20180614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hinson Andrew G
CENTRAL INDEX KEY: 0001389410
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36362
FILM NUMBER: 18899568
MAIL ADDRESS:
STREET 1: C/O BIOLIFE SOLUTIONS, INC.
STREET 2: 171 FRONT STREET
CITY: OWEGO
STATE: NY
ZIP: 13827
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC
CENTRAL INDEX KEY: 0000834365
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 943076866
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4254011400
MAIL ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: BIOLIFE SOLUTION INC
DATE OF NAME CHANGE: 20030113
FORMER COMPANY:
FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC
DATE OF NAME CHANGE: 19920703
4
1
rdgdoc.xml
FORM 4
X0306
4
2018-06-13
0000834365
BIOLIFE SOLUTIONS INC
BLFS
0001389410
Hinson Andrew G
C/O BIOLIFE SOLUTIONS, INC.
3303 MONTE VILLA PARKWAY, SUITE 310
BOTHELL
WA
98021
1
Common Stock
2018-06-13
4
M
0
10714
1.261
A
49033
D
Common Stock
2018-06-13
4
M
0
10714
1.4010
A
59747
D
Common Stock
2018-06-13
4
S
0
10000
11.25
D
49474
D
Employee Stock Option
1.261
2018-06-13
4
M
0
10714
0
D
2010-02-27
2019-02-26
Common Stock
10714
0
D
Employee Stock Option
1.4010
2018-06-13
4
M
0
10714
0
D
2011-02-05
2020-02-04
Common Stock
10714
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.10 to $11.40, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Andrew G. Hinson
2018-06-14